Literature DB >> 1605440

Current strategy in surgery for esophageal cancer.

J R Siewert1, A H Hölscher.   

Abstract

Curative surgical treatment of esophageal cancer involves the complete macroscopic and microscopic removal of the tumor (R0-resection). Only by these means the prognosis can be improved. The treatment of choice for squamous cell cancer is transthoracic en-bloc esophagectomy. Preoperative risk analysis of the patient and staging of the tumor especially by endoscopic ultrasonography are mandatory. Tumors penetrating the esophageal wall (T3, T4) above the tracheal bifurcation and T4-tumors below the bifurcation should be treated preoperatively by (radio-)chemotherapy within the framework of a multimodal therapeutic approach.

Entities:  

Mesh:

Year:  1992        PMID: 1605440

Source DB:  PubMed          Journal:  Ann Ital Chir        ISSN: 0003-469X            Impact factor:   0.766


  2 in total

1.  Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography.

Authors:  B L Brücher; W Weber; M Bauer; U Fink; N Avril; H J Stein; M Werner; F Zimmerman; J R Siewert; M Schwaiger
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

2.  Efficacy of 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a in photodynamic therapy of human esophageal squamous cancer cells.

Authors:  Dengpan Wu; Zhen Liu; Yanni Fu; Yuan Zhang; Nan Tang; Qin Wang; Liang Tao
Journal:  Oncol Lett       Date:  2013-07-25       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.